New Site Home Editors Authors Subscribers
Inventi Journals







Inventi Rapid: Pharm Tech
publication date: 2011/2/15

DESIGN AND EVALUATION OF TRANSDERMAL DRUG DELIVERY SYSTEM OF ATENOLOL AS AN ANTI-HYPERTENSIVE DRUG
                  ASHOK H. BARIA, RAKESH P. PATEL

ABSTRACT
The purpose of this research was to develop a matrix-type transdermal therapeutic system containing an antihypertensive drug, atenolol (ATL), with different concentrations of hydrophobic polymers like Eudragit RL-100 (ERL-100) and Eudragit RS-100 (ERS-100) by the solvent evaporation technique. Different concentrations of oleic acid (OA) were used to enhance the transdermal permeation of ATL. The physicochemical compatibility of the drug and the polymers was also studied by differential scanning calorimetry (DSC) and infrared (IR) spectroscopy. The results suggested no physicochemical incompatibility between the drug and the polymers. Formulated transdermal films were physically evaluated with regard to thickness, weight variation, flatness, drug content, folding endurance, % moisture uptake and % moisture content. All prepared formulations indicated good physical stability. In-vitro permeation studies of formulations were performed by using Franz diffusion cells. The results followed Higuchi kinetics, and the mechanism of release was diffusion-mediated. Formulation prepared with ERL 100 polymer containing permeation enhancer showed best in-vitro skin permeation through rat skin as compared with all other formulations.

Full Text

How to Cite This Article

ASHOK H. BARIA, RAKESH P. PATEL,  " DESIGN AND EVALUATION OF TRANSDERMAL DRUG DELIVERY SYSTEM OF ATENOLOL AS AN ANTI-HYPERTENSIVE DRUG ",  Inventi Rapid: Pharm Tech ,  Vol. 2011 , Article ID- " Inventi:pt/205/11 " 2011  [ cited 2014 Apr 17 ]  Available From  


Copyright@2011. Inventi Journals Pvt.Ltd. All Right Reserved.